Gibson Christopher
Director · Officer · RXRX, PACB
As of 2026-09-16, Gibson Christopher has 118 Form 4 transactions on record across 2 companies — 69 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in March in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | RXRX | Sale | 40,000 @ $3.62 | $145K | −4.3% of holding | 883,735 | Form 4 |
| 2026-05-22 | RXRX | Sale | 40,000 @ $3.08 | $123K | −4.3% of holding | 883,735 | Form 4 |
| 2026-05-07 | RXRX | Sale | 40,000 @ $3.37 | $135K | −4.1% of holding | 926,556 | Form 4 |
| 2026-04-22 | RXRX | Sale | 40,000 @ $3.61 | $144K | −4.2% of holding | 906,556 | Form 4 |
| 2026-04-07 | RXRX | Sale | 40,000 @ $3.10 | $124K | −4.2% of holding | 906,556 | Form 4 |
| 2026-03-23 | RXRX | Sale | 40,000 @ $3.25 | $130K | −4.2% of holding | 906,556 | Form 4 |
| 2026-02-19 | RXRX | Sale | 40,000 @ $3.46 | $138K | −4.2% of holding | 906,556 | Form 4 |
| 2026-02-04 | RXRX | Sale | 40,000 @ $4.12 | $165K | −4.2% of holding | 913,839 | Form 4 |
| 2026-01-20 | RXRX | Sale | 40,000 @ $4.47 | $179K | −4.2% of holding | 913,839 | Form 4 |
| 2026-01-05 | RXRX | Sale | 40,000 @ $4.25 | $170K | −4.1% of holding | 933,839 | Form 4 |
| 2025-12-19 | RXRX | Sale | 40,000 @ $4.50 | $180K | −4.2% of holding | 913,839 | Form 4 |
| 2025-12-04 | RXRX | Sale | 40,000 @ $4.63 | $185K | −4.1% of holding | 933,839 | Form 4 |
| 2025-11-19 | RXRX | Sale | 40,000 @ $4.16 | $166K | −4.2% of holding | 913,839 | Form 4 |
| 2025-11-04 | RXRX | Sale | 40,000 @ $5.21 | $208K | −3.9% of holding | 974,229 | Form 4 |
| 2025-10-23 | RXRX | Sale | 100,000 @ $5.70 | $570K | −9.5% of holding | 954,229 | Form 4 |
| 2025-10-10 | RXRX | Sale | 100,000 @ $6.04 | $604K | −9.3% of holding | 974,229 | Form 4 |
| 2025-09-25 | RXRX | Sale | 100,000 @ $4.76 | $476K | −9.5% of holding | 954,229 | Form 4 |
| 2025-09-10 | RXRX | Sale | 100,000 @ $4.71 | $471K | −9.3% of holding | 974,229 | Form 4 |
| 2025-08-26 | RXRX | Sale | 100,000 @ $4.84 | $484K | −9.5% of holding | 954,229 | Form 4 |
| 2025-08-11 | RXRX | Sale | 500,300 @ $5.28 | $2.6M | −33.2% of holding | 1,004,619 | Form 4 |
| 2025-08-11 | RXRX | Sale | 100,000 @ $5.28 | $528K | −100.0% of holding | 0 | Form 4 |
| 2025-08-11 | RXRX | Sale | 17,875 @ $5.28 | $94K | −100.0% of holding | 0 | Form 4 |
| 2025-03-27 | RXRX | Sale | 138,574 @ $6.04 | $837K | −11.0% of holding | 1,117,450 | Form 4 |
| 2025-03-06 | RXRX | Sale | 20,000 @ $6.37 | $127K | −1.6% of holding | 1,256,024 | Form 4 |
| 2025-03-05 | RXRX | Sale | 20,000 @ $6.58 | $132K | −1.6% of holding | 1,256,024 | Form 4 |
| 2025-02-06 | RXRX | Sale | 20,000 @ $8.12 | $162K | −1.5% of holding | 1,273,156 | Form 4 |
| 2025-02-05 | RXRX | Sale | 20,000 @ $7.68 | $154K | −1.5% of holding | 1,273,156 | Form 4 |
| 2025-01-10 | RXRX | Sale | 20,000 @ $7.05 | $141K | −2.6% of holding | 736,633 | Form 4 |
| 2025-01-08 | RXRX | Sale | 20,000 @ $7.31 | $146K | −2.6% of holding | 736,633 | Form 4 |
| 2024-12-05 | RXRX | Sale | 20,000 @ $7.12 | $142K | −2.6% of holding | 736,633 | Form 4 |
| 2024-12-04 | RXRX | Sale | 20,000 @ $7.16 | $143K | −2.6% of holding | 736,633 | Form 4 |
87 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-06-05 | RXRX | Conversion | 40,000 | 923,735 | Form 4 |
| 2026-06-05 | RXRX | Conversion | 40,000 | 4,263,334 | Form 4 |
| 2026-06-03 | PACB | Award / grant | 74,497 | 74,497 | Form 4 |
| 2026-05-22 | RXRX | Conversion | 40,000 | 4,303,334 | Form 4 |
| 2026-05-22 | RXRX | Conversion | 40,000 | 923,735 | Form 4 |
| 2026-05-15 | RXRX | Withheld for tax | 22,821 | 883,735 | Form 4 |
| 2026-05-07 | RXRX | Conversion | 60,000 | 966,556 | Form 4 |
| 2026-05-07 | RXRX | Gift | 20,000 | 906,556 | Form 4 |
| 2026-05-07 | RXRX | Conversion | 60,000 | 4,343,334 | Form 4 |
| 2026-04-22 | RXRX | Conversion | 40,000 | 4,403,334 | Form 4 |
| 2026-04-22 | RXRX | Conversion | 40,000 | 946,556 | Form 4 |
| 2026-04-08 | PACB | Award / grant | 77,842 | 77,842 | Form 4 |
| 2026-04-08 | PACB | Award / grant | 57,473 | 111,386 | Form 4 |
| 2026-04-07 | RXRX | Conversion | 40,000 | 4,443,334 | Form 4 |
| 2026-04-07 | RXRX | Conversion | 40,000 | 946,556 | Form 4 |
| 2026-03-23 | RXRX | Conversion | 40,000 | 4,483,334 | Form 4 |
| 2026-03-23 | RXRX | Conversion | 40,000 | 946,556 | Form 4 |
| 2026-03-09 | RXRX | Gift | 20,000 | 906,556 | Form 4 |
| 2026-03-09 | RXRX | Conversion | 20,000 | 4,523,334 | Form 4 |
| 2026-03-09 | RXRX | Conversion | 20,000 | 926,556 | Form 4 |
| 2026-03-03 | PACB | Award / grant | 53,913 | 53,913 | Form 4 |
| 2026-03-03 | PACB | Award / grant | 73,087 | 73,087 | Form 4 |
| 2026-02-19 | RXRX | Conversion | 40,000 | 4,543,334 | Form 4 |
| 2026-02-19 | RXRX | Conversion | 40,000 | 946,556 | Form 4 |
| 2026-02-17 | RXRX | Withheld for tax | 27,265 | 906,556 | Form 4 |
| 2026-02-06 | RXRX | Withheld for tax | 10,364 | 933,821 | Form 4 |
| 2026-02-06 | RXRX | Award / grant | 30,346 | 944,185 | Form 4 |
| 2026-02-04 | RXRX | Conversion | 40,000 | 4,583,334 | Form 4 |
| 2026-02-04 | RXRX | Conversion | 40,000 | 953,839 | Form 4 |
| 2026-01-20 | RXRX | Conversion | 40,000 | 4,623,334 | Form 4 |
| 2026-01-20 | RXRX | Conversion | 40,000 | 953,839 | Form 4 |
| 2026-01-05 | RXRX | Conversion | 60,000 | 4,663,334 | Form 4 |
| 2026-01-05 | RXRX | Gift | 20,000 | 913,839 | Form 4 |
| 2026-01-05 | RXRX | Conversion | 60,000 | 973,839 | Form 4 |
| 2025-12-19 | RXRX | Conversion | 40,000 | 4,723,334 | Form 4 |
| 2025-12-19 | RXRX | Conversion | 40,000 | 953,839 | Form 4 |
| 2025-12-04 | RXRX | Conversion | 60,000 | 4,763,334 | Form 4 |
| 2025-12-04 | RXRX | Gift | 20,000 | 913,839 | Form 4 |
| 2025-12-04 | RXRX | Conversion | 60,000 | 973,839 | Form 4 |
| 2025-11-19 | RXRX | Conversion | 40,000 | 4,823,334 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.